{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:47:21Z","timestamp":1786981641089,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T00:00:00Z","timestamp":1538438400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T00:00:00Z","timestamp":1538438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["a Grant-in-Aid for Young Scientists (B) (15K18921)"],"award-info":[{"award-number":["a Grant-in-Aid for Young Scientists (B) (15K18921)"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["a Grant-in-Aid for Scientific Research (B) (15H04639)"],"award-info":[{"award-number":["a Grant-in-Aid for Scientific Research (B) (15H04639)"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"the Takeda Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008732","name":"the Uehara Memorial Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Takahashi Industrial and Economic Research Foundation"},{"DOI":"10.13039\/501100005623","name":"University of Tokushima","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005623","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s11095-018-2505-3","type":"journal-article","created":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T11:33:19Z","timestamp":1538479999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["A Cell Assay for Detecting Anti-PEG Immune Response against PEG-Modified Therapeutics"],"prefix":"10.1007","volume":"35","author":[{"given":"Taro","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr S.","family":"Abu Lila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Awata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiyo","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Mima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichiro","family":"Okuhira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuhiro","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,2]]},"reference":[{"issue":"2","key":"2505_CR1","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1021\/bc00032a002","volume":"6","author":"S Zalipsky","year":"1995","unstructured":"Zalipsky S. Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates. Bioconjug Chem. 1995 Mar-Apr;6(2):150\u201365.","journal-title":"Bioconjug Chem"},{"issue":"4","key":"2505_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0169-409X(02)00022-4","volume":"54","author":"MJ Roberts","year":"2002","unstructured":"Roberts MJ, Bentley MD, Harris JM. Chemistry for peptide and protein PEGylation. Adv Drug Deliv Rev. 2002 Jun 17;54(4):459\u201376.","journal-title":"Adv Drug Deliv Rev"},{"key":"2505_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2147\/NSA.S8984","volume":"3","author":"RK Delong","year":"2010","unstructured":"Delong RK, Reynolds CM, Malcolm Y, Schaeffer A, Severs T, Wanekaya A. Functionalized gold nanoparticles for the binding, stabilization, and delivery of therapeutic DNA, RNA, and other biological macromolecules. Nanotechnol Sci Appl. 2010 Sep 20;3:53\u201363.","journal-title":"Nanotechnol Sci Appl"},{"issue":"3","key":"2505_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.4155\/tde.14.5","volume":"5","author":"A Patel","year":"2014","unstructured":"Patel A, Cholkar K, Mitra AK. Recent developments in protein and peptide parenteral delivery approaches. Ther Deliv. 2014 Mar;5(3):337\u201365.","journal-title":"Ther Deliv"},{"issue":"6","key":"2505_CR5","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s13346-013-0176-5","volume":"3","author":"JJ Verhoef","year":"2013","unstructured":"Verhoef JJ, Anchordoquy TJ. Questioning the use of PEGylation for drug delivery. Drug Deliv Transl Res. 2013 Dec;3(6):499\u2013503.","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"2505_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1124\/jpet.114.217208","volume":"351","author":"G Mattheolabakis","year":"2014","unstructured":"Mattheolabakis G, Wong CC, Sun Y, Amella CA, Richards R, Constantinides PP, et al. Pegylation improves the pharmacokinetics and bioavailability of small-molecule drugs hydrolyzable by esterases: a study of phospho-ibuprofen. J Pharmacol Exp Ther. 2014 Oct;351(1):61\u20136.","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"2505_CR7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0936-6555(05)80269-9","volume":"6","author":"ND James","year":"1994","unstructured":"James ND, Coker RJ, Tomlinson D, Harris JR, Gompels M, Pinching AJ, et al. Liposomal doxorubicin (Doxil): an effective new treatment for Kaposi's sarcoma in AIDS. Clin Oncol (R Coll Radiol). 1994;6(5):294\u20136.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"2505_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.addr.2007.06.011","volume":"60","author":"MR Sherman","year":"2008","unstructured":"Sherman MR, Saifer MG, Perez-Ruiz F. PEG-uricase in the management of treatment-resistant gout and hyperuricemia. Adv Drug Deliv Rev. 2008 Jan 03;60(1):59\u201368.","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"2505_CR9","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0149-2918(04)90173-7","volume":"26","author":"SJ Matthews","year":"2004","unstructured":"Matthews SJ, McCoy C. Peginterferon alfa-2a: a review of approved and investigational uses. Clin Ther. 2004 Jul;26(7):991\u20131025.","journal-title":"Clin Ther"},{"issue":"11","key":"2505_CR10","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1517\/17425247.2012.720969","volume":"9","author":"RP Garay","year":"2012","unstructured":"Garay RP, El-Gewely R, Armstrong JK, Garratty G, Richette P. Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents. Expert Opin Drug Deliv. 2012 Nov;9(11):1319\u201323.","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"2505_CR11","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jconrel.2013.03.008","volume":"172","author":"Q Huang","year":"2013","unstructured":"Huang Q, Li D, Kang A, An W, Fan B, Ma X, et al. PEG as a spacer arm markedly increases the immunogenicity of meningococcal group Y polysaccharide conjugate vaccine. J Control Release. 2013 Nov 28;172(1):382\u20139.","journal-title":"J Control Release"},{"issue":"7","key":"2505_CR12","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1007\/s11095-013-1067-7","volume":"30","author":"H Schellekens","year":"2013","unstructured":"Schellekens H, Hennink WE, Brinks V. The immunogenicity of polyethylene glycol: facts and fiction. Pharm Res. 2013 Jul;30(7):1729\u201334.","journal-title":"Pharm Res"},{"issue":"5","key":"2505_CR13","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/wnan.1339","volume":"7","author":"Q Yang","year":"2015","unstructured":"Yang Q, Lai SK. Anti-PEG immunity: emergence, characteristics, and unaddressed questions. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015 Sep-Oct;7(5):655\u201377.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"Pt A","key":"2505_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","volume":"99","author":"JS Suk","year":"2016","unstructured":"Suk JS, Xu Q, Kim N, Hanes J, Ensign LM. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 2016 Apr 01;99(Pt A):28\u201351.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"2505_CR15","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0022-3565(24)35391-1","volume":"292","author":"ET Dams","year":"2000","unstructured":"Dams ET, Laverman P, Oyen WJ, Storm G, Scherphof GL, van Der Meer JW, et al. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. J Pharmacol Exp Ther. 2000 Mar;292(3):1071\u20139.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"2505_CR16","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0022-3565(24)29419-2","volume":"298","author":"P Laverman","year":"2001","unstructured":"Laverman P, Carstens MG, Boerman OC, Dams ET, Oyen WJ, van Rooijen N, et al. Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection. J Pharmacol Exp Ther. 2001 Aug;298(2):607\u201312.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"2505_CR17","first-page":"286","volume":"7","author":"T Ishida","year":"2002","unstructured":"Ishida T, Maeda R, Ichihara M, Mukai Y, Motoki Y, Manabe Y, et al. The accelerated clearance on repeated injection of pegylated liposomes in rats: laboratory and histopathological study. Cell Mol Biol Lett. 2002;7(2):286.","journal-title":"Cell Mol Biol Lett"},{"issue":"2","key":"2505_CR18","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.ymthe.2005.09.014","volume":"13","author":"A Judge","year":"2006","unstructured":"Judge A, McClintock K, Phelps JR, Maclachlan I. Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes. Mol Ther. 2006 Feb;13(2):328\u201337.","journal-title":"Mol Ther"},{"issue":"8","key":"2505_CR19","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1248\/bpb.b12-00276","volume":"35","author":"T Shimizu","year":"2012","unstructured":"Shimizu T, Ichihara M, Yoshioka Y, Ishida T, Nakagawa S, Kiwada H. Intravenous administration of polyethylene glycol-coated (PEGylated) proteins and PEGylated adenovirus elicits an anti-PEG immunoglobulin M response. Biol Pharm Bull. 2012;35(8):1336\u201342.","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"2505_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.taap.2014.03.002","volume":"277","author":"Y Hashimoto","year":"2014","unstructured":"Hashimoto Y, Shimizu T, Mima Y, Abu Lila AS, Ishida T, Kiwada H. Generation, characterization and in vivo biological activity of two distinct monoclonal anti-PEG IgMs. Toxicol Appl Pharmacol. 2014 May 15;277(1):30\u20138.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1\u20132","key":"2505_CR21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.ijpharm.2012.11.015","volume":"441","author":"A Nagao","year":"2013","unstructured":"Nagao A, Abu Lila AS, Ishida T, Kiwada H. Abrogation of the accelerated blood clearance phenomenon by SOXL regimen: promise for clinical application. Int J Pharm. 2013 Jan 30;441(1\u20132):395\u2013401.","journal-title":"Int J Pharm"},{"issue":"3","key":"2505_CR22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0021-9258(18)70227-5","volume":"234","author":"GR Bartlett","year":"1959","unstructured":"Bartlett GR. Colorimetric assay methods for free and phosphorylated glyceric acids. J Biol Chem. 1959 Mar;234(3):469\u201371.","journal-title":"J Biol Chem"},{"issue":"7","key":"2505_CR23","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1021\/acs.molpharmaceut.5b00144","volume":"12","author":"Y Mima","year":"2015","unstructured":"Mima Y, Hashimoto Y, Shimizu T, Kiwada H, Ishida T. Anti-PEG IgM is a major contributor to the accelerated blood clearance of polyethylene glycol-conjugated protein. Mol Pharm. 2015 Jul 06;12(7):2429\u201335.","journal-title":"Mol Pharm"},{"issue":"11","key":"2505_CR24","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1248\/bpb.b13-00562","volume":"36","author":"AS Abu Lila","year":"2013","unstructured":"Abu Lila AS, Ichihara M, Shimizu T, Ishida T, Kiwada H. Ex-vivo\/in-vitro anti-polyethylene glycol (PEG) immunoglobulin M production from murine splenic B cells stimulated by PEGylated liposome. Biol Pharm Bull. 2013;36(11):1842\u20138.","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"2505_CR25","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ejpb.2018.02.019","volume":"127","author":"T Shimizu","year":"2018","unstructured":"Shimizu T, Abu Lila AS, Fujita R, Awata M, Kawanishi M, Hashimoto Y, et al. A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomes. Eur J Pharm Biopharm. 2018 Jun 1;127(1):142\u20139.","journal-title":"Eur J Pharm Biopharm"},{"issue":"19","key":"2505_CR26","doi-asserted-by":"publisher","first-page":"8766","DOI":"10.1073\/pnas.1003854107","volume":"107","author":"P Farci","year":"2010","unstructured":"Farci P, Diaz G, Chen Z, Govindarajan S, Tice A, Agulto L, et al. B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failure. Proc Natl Acad Sci U S A. 2010 May 11;107(19):8766\u201371.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2505_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ijpharm.2013.07.059","volume":"456","author":"AS Abu Lila","year":"2013","unstructured":"Abu Lila AS, Nawata K, Shimizu T, Ishida T, Kiwada H. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration. Int J Pharm. 2013 Nov 01;456(1):235\u201342.","journal-title":"Int J Pharm"},{"issue":"4","key":"2505_CR28","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1084\/jem.20060087","volume":"203","author":"D Paus","year":"2006","unstructured":"Paus D, Phan TG, Chan TD, Gardam S, Basten A, Brink R. Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation. J Exp Med. 2006 Apr 17;203(4):1081\u201391.","journal-title":"J Exp Med"},{"issue":"6","key":"2505_CR29","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.4049\/jimmunol.146.6.1791","volume":"146","author":"PK Mongini","year":"1991","unstructured":"Mongini PK, Blessinger CA, Dalton JP. Affinity requirements for induction of sequential phases of human B cell activation by membrane IgM-cross-linking ligands. J Immunol. 1991 Mar 15;146(6):1791\u2013800.","journal-title":"J Immunol"},{"key":"2505_CR30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jim.2014.07.004","volume":"413","author":"M Kuhne","year":"2014","unstructured":"Kuhne M, Dippong M, Flemig S, Hoffmann K, Petsch K, Schenk JA, et al. Comparative characterization of mAb producing hapten-specific hybridoma cells by flow cytometric analysis and ELISA. J Immunol Methods. 2014 Nov;413:45\u201356.","journal-title":"J Immunol Methods"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-018-2505-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-018-2505-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-018-2505-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:58:59Z","timestamp":1761094739000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-018-2505-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,2]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["2505"],"URL":"https:\/\/doi.org\/10.1007\/s11095-018-2505-3","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,2]]},"assertion":[{"value":"26 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"223"}}